Philip Brenner

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF AFFECTIVE DISORDERS. 2025;386:119419
Risk of major adverse cardiovascular events in treatment-resistant or severe depression
Nygren A; Reutfors J; Karlsson P; Tiger M; Faxen J; Brenner P
Journal article: SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY. 2025;:1-12
Psychiatric outcomes and long-term school and work-related disability in offspring of parents with depression and treatment-resistant depression
Brenner P; Taipale H; Josefsson P; Dibernardo A; Tanskanen A; Mittendorfer-Rutz E; Reutfors J
Article: GENERAL HOSPITAL PSYCHIATRY. 2024;89:23-31
Association between inflammatory joint disease and severe or treatment-resistant depression: population-based cohort and case-control studies in Sweden
Brenner P; Askling J; Hagg D; Brandt L; Stang P; Reutfors J
Article: INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 2022;26(3):251-258
Health care utilisation in treatment-resistant depression: a Swedish population-based cohort study
Brenner P; Nygren A; Hagg D; Tiger M; O'Hara M; Brandt L; Reutfors J
Journal article: NEUROSCIENCE APPLIED. 2022;1:100228
Trends in hypnotic drug use in depression 2007 – 2017: a Swedish population-based study
Reutfors J; Brandt L; Cabrera P; Karlsson P; Eloranta S; Brenner P
Article: ARCHIVES OF SUICIDE RESEARCH. 2021;25(3):424-438
Risk Factors for Suicide and Suicide Attempts Among Patients With Treatment-Resistant Depression: Nested Case-Control Study
Reutfors J; Andersson TM-L; Tanskanen A; DiBernardo A; Li G; Brandt L; Brenner P
Article: THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY. 2021;11:20451253211006508
Excess deaths in treatment-resistant depression
Brenner P; Reutfors J; Nijs M; Andersson TM-L
Article: PLOS ONE. 2020;15(7):e0236434
A register-based approach to identifying treatment-resistant depression-Comparison with clinical definitions
Hagg D; Brenner P; Reutfors J; Li G; DiBernardo A; Boden R; Brandt L
Article: BMC PSYCHIATRY. 2020;20(1):232
Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study
Taipale H; Reutfors J; Tanskanen A; Brandt L; Tiihonen J; DiBernardo A; Mittendorfer-Rutz E; Brenner P
Article: ADDICTION. 2020;115(4):768-777
Substance use disorders and risk for treatment resistant depression: a population-based, nested case-control study
Brenner P; Brandt L; Li G; DiBernardo A; Boden R; Reutfors J
Article: DRUG SAFETY. 2020;43(2):135-145
A Post-Authorization Safety Study of Quetiapine as Antidepressant Treatment in Sweden: Nested Case-Control Analyses of Select Outcomes
Reutfors J; Brenner P; Brody B; Wray H; Andersen M; Brandt L
Article: BMC RHEUMATOLOGY. 2020;4(1):9
Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
Brenner P; Citarella A; Wingard L; Sundstrom A
Article: NEUROLOGY. 2019;93(24):e2216-e2223
Disability worsening among persons with multiple sclerosis and depression A Swedish cohort study
Binzer S; McKay KA; Brenner P; Hillert J; Manouchehrinia A
Article: ANNALS OF GENERAL PSYCHIATRY. 2019;18(1):23
All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population
Li G; Fife D; Wang G; Sheehan JJ; Boden R; Brandt L; Brenner P; Reutfors J; DiBernardo A
Article: ADDICTION. 2019;114(7):1274-1282
Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study
Brenner P; Brandt L; Li G; DiBernardo A; Boden R; Reutfors J
Article: BMC PSYCHIATRY. 2018;18(1):352
Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study
DiBernardo A; Lin X; Zhang Q; Xiang J; Lu L; Jamieson C; Benson C; Lee K; Boden R; Brandt L; Brenner P; Reutfors J; Li G
Article: JOURNAL OF AFFECTIVE DISORDERS. 2018;238:674-679
Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden
Reutfors J; Andersson TM-L; Brenner P; Brandt L; DiBernardo A; Li G; Hagg D; Wingard L; Boden R
Article: PSYCHONEUROENDOCRINOLOGY. 2018;89:53-58
Depression and fatigue in multiple sclerosis: Relation to exposure to violence and cerebrospinal fluid immunomarkers
Brenner P; Granqvist M; Konigsson J; Al Nimer F; Piehl F; Jokinen J
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2016;23(8):1329-1336
Multiple sclerosis and risk of attempted and completed suicide - a cohort study
Brenner P; Burkill S; Jokinen J; Hillert J; Bahmanyar S; Montgomery S
Article: SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY. 2016;51(7):1047-1054
Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls
Brenner P; Mittendorfer-Rutz E; Jokinen J; Alexanderson K; Hillert J; Tinghog P
Article: BRAIN BEHAVIOR AND IMMUNITY. 2016;51:47-55
Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms
Aeinehband S; Brenner P; Stahl S; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
Article: BMC PSYCHIATRY. 2015;15:286
Is disability pension a risk indicator for future need of psychiatric healthcare or suicidal behavior among MS patients- a nationwide register study in Sweden?
Bjorkenstam C; Tinghog P; Brenner P; Mittendorfer-Rutz E; Hillert J; Jokinen J; Alexanderson K
Journal article: NEUROLOGY. 2015;84(14_supplement)
National Swedish MS Register Based Study: the Symbol Digit Modalities Test as a predictor of work disability (P3.222)
Karrenbauer V; Brenner P; Hillert J; Tinghög P
Article: PLOS ONE. 2014;9(8):e104165
Psychiatric Diagnoses, Medication and Risk for Disability Pension in Multiple Sclerosis Patients; a Population-Based Register Study
Brenner P; Alexanderson K; Bjorkenstam C; Hillert J; Jokinen J; Mittendorfer-Rutz E; Tinghog P
Visa fler

Alla övriga publikationer

Conference publication: NEUROSCIENCE APPLIED. 2023;2:102907
Healthcare and psychiatric drug utilization after a suicide attempt in depression: a matched cohort study from Swedish nationwide registers
Johansson V; Brenner P; Karlsson P; Borentain S; Feldman A; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022;31:368-369
Prescribing patterns for glucagon-like peptide-1 receptor agonists following the introduction of semaglutide in Denmark and Norway
Rasmussen L; Andersen JH; Furu K; Karlstad O; Brenner P; Pottegard A
Conference publication: EUROPEAN PSYCHIATRY. 2022;65:S111
Association with severe and treatment-resistant depression among patients with inflammatory joint disease. Nationwide nested case-control study in Swedish registers.
Brenner P; Askling J; Stang P; Brandt L; Hagg D; Reutfors J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021;53:S77
Health care utilization in treatment-resistant depression: a Swedish population based cohort study
Brenner P; Nygren A; Hagg D; Tiger M; O'Hara M; Brandt L; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29:70
Excess deaths associated with treatment resistance in patients with major depressive disorder
Brenner P; Brandt L; Nijs M; Reutfors J; Andersson T
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S48-S49
Risk for disability pension among antidepressant treated patients with and without treatment resistant depression: matched cohort study in Swedish registers
Taipale H; Reutfors J; Tanskanen A; Tiihonen J; Mittendorfer-Rutz E; DiBernardo A; Brandt L; Brenner P
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2019;28:99
Risk factors for suicide and suicide attempts among patients with treatment resistant depression: A population based nested case-control study
Brenner P; Andersson TM-L; Tanskanen A; DiBernardo A; Li G; Brandt L; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27:152
Treatment resistant depression as a risk factor for substance use disorders-A national register-based cohort study
Brenner P; Hagg D; DiBernardo A; Li G; Boden R; Brandt L; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27:153
Substance use disorders are risk factors for treatment resistant depression
Brenner P; Brandt L; Hagg D; Li G; DiBernardo A; Boden R; Reutfors J
Doctoral thesis: 2017
Psychiatric comorbidity in multiple sclerosis : biological and epidemiological aspects
Brenner P
Review: ACTA NEUROLOGICA SCANDINAVICA. 2016;134:47-54
Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions
Brenner P; Piehl F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:23-24
Multiple sclerosis and risk of completed and attempted suicide - a national cohort study
Brenner P; Burkill S; Jokinen J; Moore A; Geissbuehler Y; Hillert J; Bahmanyar S; Montgomery S
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:351-352
Cerebrospinal fluid kynurenines in multiple sclerosis: relation to disease course and neurocognitive symptoms
Stahl S; Aeinehband S; Brenner P; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
Conference publication: EUROPEAN PSYCHIATRY. 2015;30:616
Psychiatric Drug Consumption Among Multiple Sclerosis Patients Before and After Disability Pension; a Controlled Register Study
Brenner P; Mittendorfer-Rutz E; Jokinen J; Alexandersson K; Hillert J; Tinghog P
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2014;20:389
Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study
Brenner P; Jokinen J; Bjorkenstam C; Hillert J; Rutz EM; Alexandersson K; Tinghog P

Anställningar

Adjungerad Adjunkt, Klinisk neurovetenskap, Karolinska Institutet, 2023-2026

Examina och utbildning

Docent, Psykiatri, Karolinska Institutet, 2022
Medicine Doktorsexamen, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2017

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI